Shopping Cart 0
Cart Subtotal
USD 0

Genovis AB (GENO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Genovis AB (Genovis) develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company's products are used for antibody molecules analysis to identify and characterize proteins, antibody based biotherapeutics; monoclonal antibodies, antibody drug conjugates and biosimilars. Its SmartEnzymes product portfolio encompasses FabRICATOR (IdeS), GingisKHAN (KGP), FabULOUS (SpeB), GlycINATOR (EndoS49), FabRICATOR Z (IdeZ), GingisREX (Rgp) and IgGZERO (EndoS). Genovis also offers antibody fragmentation services for different species and subclasses of Immunoglobulin G antibodies. The company offers its products to medical device, pharmaceutical and biotechnology sectors as well as contract manufacturing companies. It has presence in Massachusetts, the US; Europe and other countries. Genovis is headquartered in Lund, Sweden.

Genovis AB (GENO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genovis AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Genovis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genovis AB, Medical Devices Deals, 2012 to YTD 2018 8

Genovis AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Genovis AB, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Genovis Enters Distribution Agreement with Shanghai Titan Scientific 10

Genovis Partners with Alphalyse 11

Genovis Enters Into Distribution Agreement With Sigma-Aldrich 12

Licensing Agreements 13

Life Technologies Enters into Licensing Agreement with Genovis 13

Equity Offering 14

Genovis to Raise USD1.2 Million in Rights Offering of Shares 14

Genovis to Raise USD1.3 Million in Rights Offering of Shares 15

Genovis Raises USD2.7 Million in Rights Offering of Shares 16

Genovis Raises USD1.7 Million in Rights Issue of Shares 17

Genovis Completes Rights Offering ff Shares for USD3.6 Million 18

Genovis Announces Private Placement Of Shares For USD 0.5 Million 19

Genovis Completes Rights Issue Of Shares For USD 2 Million 20

Genovis Raises USD1.8 Million in Rights Issue of Shares 21

Genovis AB-Key Competitors 22

Genovis AB-Key Employees 23

Genovis AB-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Financial Announcements 25

Aug 28, 2018: Genovis: Half-yearly report January-June 2018 25

May 15, 2018: Genovis: Interim Report January-March 2018 27

Nov 27, 2017: Genovis Announces Interim Report January-September 2017 29

Feb 27, 2017: Genovis Announces Year-End Report January-December 2016 30

Corporate Communications 36

Apr 23, 2018: Proposal to expand the Genovis Board of Directors at 2018 Annual General Meeting 36

Product News 37

Sep 18, 2018: Genovis launches FabRICATOR-HPLC for automated antibody analysis 37

Apr 26, 2018: Genovis launches GlycOCATCH for purification of O-glycosylated proteins 38

Other Significant Developments 39

Dec 08, 2017: Genovis Signs Distribution Agreement in India 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Genovis AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Genovis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genovis AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Genovis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genovis AB, Medical Devices Deals, 2012 to YTD 2018 8


List Of Table

List of Tables

Genovis AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Genovis AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genovis AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Genovis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genovis AB, Medical Devices Deals, 2012 to YTD 2018 8

Genovis AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Genovis Enters Distribution Agreement with Shanghai Titan Scientific 10

Genovis Partners with Alphalyse 11

Genovis Enters Into Distribution Agreement With Sigma-Aldrich 12

Life Technologies Enters into Licensing Agreement with Genovis 13

Genovis to Raise USD1.2 Million in Rights Offering of Shares 14

Genovis to Raise USD1.3 Million in Rights Offering of Shares 15

Genovis Raises USD2.7 Million in Rights Offering of Shares 16

Genovis Raises USD1.7 Million in Rights Issue of Shares 17

Genovis Completes Rights Offering ff Shares for USD3.6 Million 18

Genovis Announces Private Placement Of Shares For USD 0.5 Million 19

Genovis Completes Rights Issue Of Shares For USD 2 Million 20

Genovis Raises USD1.8 Million in Rights Issue of Shares 21

Genovis AB, Key Competitors 22

Genovis AB, Key Employees 23

Genovis AB, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Genovis AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Genovis AB (Genovis) develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company's products are used for antibody molecules analysis to identify and characterize proteins, antibody based biotherapeutics; monoclonal antibodies, antibody drug conjugates and biosimilars. Its SmartEnzymes product portfolio encompasses FabRICATOR (IdeS), GingisKHAN (KGP), FabULOUS (SpeB), GlycINATOR (EndoS49), FabRICATOR Z (IdeZ), GingisREX (Rgp) and IgGZERO (EndoS). Genovis also offers antibody fragmentation services for different species and subclasses of Immunoglobulin G antibodies. The company offers its products to medical device, pharmaceutical and biotechnology sectors as well as contract manufacturing companies. It has presence in Massachusetts, the US; Europe and other countries. Genovis is headquartered in Lund, Sweden.

Genovis AB (GENO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genovis AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Genovis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genovis AB, Medical Devices Deals, 2012 to YTD 2018 8

Genovis AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Genovis AB, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Genovis Enters Distribution Agreement with Shanghai Titan Scientific 10

Genovis Partners with Alphalyse 11

Genovis Enters Into Distribution Agreement With Sigma-Aldrich 12

Licensing Agreements 13

Life Technologies Enters into Licensing Agreement with Genovis 13

Equity Offering 14

Genovis to Raise USD1.2 Million in Rights Offering of Shares 14

Genovis to Raise USD1.3 Million in Rights Offering of Shares 15

Genovis Raises USD2.7 Million in Rights Offering of Shares 16

Genovis Raises USD1.7 Million in Rights Issue of Shares 17

Genovis Completes Rights Offering ff Shares for USD3.6 Million 18

Genovis Announces Private Placement Of Shares For USD 0.5 Million 19

Genovis Completes Rights Issue Of Shares For USD 2 Million 20

Genovis Raises USD1.8 Million in Rights Issue of Shares 21

Genovis AB-Key Competitors 22

Genovis AB-Key Employees 23

Genovis AB-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Financial Announcements 25

Aug 28, 2018: Genovis: Half-yearly report January-June 2018 25

May 15, 2018: Genovis: Interim Report January-March 2018 27

Nov 27, 2017: Genovis Announces Interim Report January-September 2017 29

Feb 27, 2017: Genovis Announces Year-End Report January-December 2016 30

Corporate Communications 36

Apr 23, 2018: Proposal to expand the Genovis Board of Directors at 2018 Annual General Meeting 36

Product News 37

Sep 18, 2018: Genovis launches FabRICATOR-HPLC for automated antibody analysis 37

Apr 26, 2018: Genovis launches GlycOCATCH for purification of O-glycosylated proteins 38

Other Significant Developments 39

Dec 08, 2017: Genovis Signs Distribution Agreement in India 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Genovis AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Genovis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genovis AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Genovis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genovis AB, Medical Devices Deals, 2012 to YTD 2018 8


List Of Table

List of Tables

Genovis AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Genovis AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genovis AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Genovis AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genovis AB, Medical Devices Deals, 2012 to YTD 2018 8

Genovis AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Genovis Enters Distribution Agreement with Shanghai Titan Scientific 10

Genovis Partners with Alphalyse 11

Genovis Enters Into Distribution Agreement With Sigma-Aldrich 12

Life Technologies Enters into Licensing Agreement with Genovis 13

Genovis to Raise USD1.2 Million in Rights Offering of Shares 14

Genovis to Raise USD1.3 Million in Rights Offering of Shares 15

Genovis Raises USD2.7 Million in Rights Offering of Shares 16

Genovis Raises USD1.7 Million in Rights Issue of Shares 17

Genovis Completes Rights Offering ff Shares for USD3.6 Million 18

Genovis Announces Private Placement Of Shares For USD 0.5 Million 19

Genovis Completes Rights Issue Of Shares For USD 2 Million 20

Genovis Raises USD1.8 Million in Rights Issue of Shares 21

Genovis AB, Key Competitors 22

Genovis AB, Key Employees 23

Genovis AB, Subsidiaries 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Genovis AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.